Sign in

Nick Cash

Research Analyst at Goldman Sachs Group Inc.

No publicly available information could be found confirming the existence of a Nick Cash currently serving as an analyst at Goldman Sachs Group, Inc. Details such as exact job title, company coverage, performance metrics, career timeline, and professional credentials could not be confirmed from trusted sources or LinkedIn. There is no evidence of his analyst rankings, securities licenses, or previous experience at Goldman Sachs or other investment firms.

Nick Cash's questions to PENTAIR (PNR) leadership

Question · Q3 2025

Nick Cash followed up on the Hydrostat acquisition, asking about its $50 million revenue for 2025, if that's a good model for 2026, and inquiring about cross-selling opportunities and its growth rate from 2024 to 2025.

Answer

CFO Bob Fishman confirmed that $50 million at 30% ROS is a good number for 2026, noting Hydrostat's historical high single-digit growth. He emphasized cross-selling opportunities by leveraging existing specifications and providing an extended offering, similar to past integrations, to open up aggressive cross-selling in 2026 and 2027.

Ask follow-up questions

Question · Q3 2025

Nick Cash followed up on the Hydra-Stop acquisition, noting its $50 million revenue in 2025 and its suitability as a model for 2026. He asked about potential cross-selling opportunities, the ability to accelerate growth in 2026, and the company's growth rate from 2024 to 2025.

Answer

CFO Bob Fishman confirmed Hydra-Stop's historical growth rate was roughly high single digits and saw no reason for it to slow in 2026. He emphasized significant cross-selling opportunities by leveraging existing specifications, similar to the successful integration of Manitowoc and Everpure. He highlighted Hydra-Stop's unique product in water infrastructure as a key factor for aggressive cross-selling in 2026 and 2027.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts